Track topics on Twitter Track topics that are important to you
With pivotal data for a Celgene CAR-T therapy set to soon be unveiled, the clock is ticking on a timeline that will determine whether Bristol-Myers pays billions more to the biotech's shareholders.
Original Article: Celgene's last hurrah at ASH a defining moment for Bristol-Myers' buyoutNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...